Beacon Biosignals

Boston, United States

Beacon Biosignals is a neurotechnology company that brings precision neuroscience into clinical trials and treatments.

$86.0M raised

Apr 2026

Series B

Artificial Intelligence (AI)Health Care Health Diagnostics Machine Learning Medical Device

Top Investors

General CatalystAlumni VenturesSamsung NEXTCatalio Capital ManagementTakeda

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Beacon Biosignals

How much funding has Beacon Biosignals raised?

Beacon Biosignals has raised $86.0M in total funding. The most recent round was Series B. The last funding was announced in April 2026.

Who are Beacon Biosignals's investors?

Beacon Biosignals's investors include General Catalyst, Alumni Ventures, Samsung NEXT, Catalio Capital Management, Takeda.

Where is Beacon Biosignals headquartered?

Beacon Biosignals is headquartered in Boston, United States.

What does Beacon Biosignals do?

Beacon Biosignals is a neurotechnology company that brings precision neuroscience into clinical trials and treatments.

What stage is Beacon Biosignals at?

Beacon Biosignals is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 6, 2026.

MLA

"Beacon Biosignals — Funding & Investors." VCBacked, April 6, 2026, https://www.vcbacked.co/company/beacon-biosignals. Accessed June 3, 2026.

APA

VCBacked. (2026). Beacon Biosignals — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/beacon-biosignals

Wikipedia (cite web)

{{cite web |title=Beacon Biosignals — Funding & Investors |url=https://www.vcbacked.co/company/beacon-biosignals |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 6, 2026.

Similar Companies in Artificial Intelligence (AI)